Precision Medicine

Researchers have developed an AI-based system that can direct the administering of iron and other red-blood-cell stimulators nearly as well as experienced physicians.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.

The FDA has greenlit an AI algorithm that automatically measures dilation in the heart’s right ventricle on CT images.

The advance represents the first cancer-care pathway offering an automatically combined analysis of morphological, molecular and histological data. 

The COVID crisis has spurred clinical researchers to look myriad ways AI might help win the war against the virus. Has the investigatory boomlet ended up raising as many nettlesome concerns as positive possibilities?

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.

Harvard researchers have used machine learning to find molecular features in existing drugs that may be effective in warding off or treating Alzheimer’s disease.

If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.

AI can be taught to flag possible skin cancers on photos taken with smartphone cameras—and the images can be ordinary “people shots” rather than closeups of suspicious lesions.

Only two of 34 representative studies evaluating the use of AI for real-world shared clinical decisionmaking from 2014 to 2020 included external validation of the models up for consideration.

Healthcare AI is advancing too quickly for its users to fully comprehend the implications of its design, development and applications, according to bioethics specialists who scanned the literature. 

The tool makes the call based on factors readily available to busy clinicians, respecting their workflows while helping patients and families decide whether moving to access a stepped-up care setting would fit well with their aims and values.

Around the web

Two different companies announced that they are recalling all lots of the medication. 

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

Trimed Popup
Trimed Popup